应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KRYS Krystal Biotech Inc.
未开盘 07-02 16:00:00 EDT
177.61
-4.66
-2.56%
盘后
177.61
+0.00
0.00%
19:06 EDT
最高
183.37
最低
177.36
成交量
33.13万
今开
181.82
昨收
182.27
日振幅
3.30%
总市值
50.72亿
流通市值
37.36亿
总股本
2,856万
成交额
5,928万
换手率
1.58%
流通股本
2,104万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Krystal Biotech, Inc.盘中异动 临近午盘股价大涨5.07%报186.48美元
自选股智能写手 · 06-12
Krystal Biotech, Inc.盘中异动 临近午盘股价大涨5.07%报186.48美元
Krystal Biotech, Inc.盘中异动 早盘股价大涨5.26%
自选股智能写手 · 06-03
Krystal Biotech, Inc.盘中异动 早盘股价大涨5.26%
美国研究综述-Agiliti、Domino's、Krystal 生物技术公司
Reuters · 02-27
美国研究综述-Agiliti、Domino's、Krystal 生物技术公司
美国研究综述-Agiliti、多米诺比萨、Krystal 生物技术公司
Reuters · 02-27
美国研究综述-Agiliti、多米诺比萨、Krystal 生物技术公司
加载更多
公司概况
公司名称:
Krystal Biotech Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Krystal Biotech, Inc.于2016年4月开始运营。2017年3月,他们从加利福尼亚州有限责任公司转换为特拉华州C-corporation,并将其名称从Krystal Biotech, LLC更改为Krystal Biotech, Inc。该公司是一家专注于为罕见病患者开发和商业化基因药物的生物技术公司。利用他们基于工程化HSV-1的专利平台,他们创造了载体,可以有效地将治疗性转基因传递给多器官系统中感兴趣的细胞。然后,细胞自身的机制转录并翻译编码的效应物来治疗或预防疾病。他们在医疗保健专业人员的办公室或可能由医疗保健专业人员在患者家中制定无创或微创给药途径的载体。他们的目标是开发易于使用的药物,以显著改善患有罕见疾病和慢性疾病的患者的生活。
发行价格:
--
{"stockData":{"symbol":"KRYS","market":"US","secType":"STK","nameCN":"Krystal Biotech Inc.","latestPrice":177.61,"timestamp":1719950400000,"preClose":182.27,"halted":0,"volume":331336,"hourTrading":{"tag":"盘后","latestPrice":177.61,"preClose":177.61,"latestTime":"19:06 EDT","volume":65203,"amount":11580653.582,"timestamp":1719961610046},"delay":0,"floatShares":21035864,"shares":28558440,"eps":1.988198,"marketStatus":"未开盘","marketStatusCode":0,"change":-4.66,"latestTime":"07-02 16:00:00 EDT","open":181.82,"high":183.37,"low":177.36,"amount":59279164.71872,"amplitude":0.032973,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.988198,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"listingDate":1505880000000,"adjPreClose":182.27,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":181.18,"preClose":182.27,"latestTime":"09:19 EDT","volume":64,"amount":11595.52,"timestamp":1719926362999},"postHourTrading":{"tag":"盘后","latestPrice":177.61,"preClose":177.61,"latestTime":"19:06 EDT","volume":65203,"amount":11580653.582,"timestamp":1719961610046},"volumeRatio":0.769327,"impliedVol":0.5239,"impliedVolPercentile":0.3492},"requestUrl":"/m/hq/s/KRYS","defaultTab":"news","newsList":[{"id":"2442456941","title":"Krystal Biotech, Inc.盘中异动 临近午盘股价大涨5.07%报186.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442456941","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442456941?lang=zh_cn&edition=full","pubTime":"2024-06-12 23:32","pubTimestamp":1718206358,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日23时32分,Krystal Biotech, Inc.股票出现波动,股价大幅拉升5.07%。Krystal Biotech, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。Krystal Biotech, Inc.公司简介:Krystal Biotech Inc在美国从事医疗保健行业。消息层面,截至23时32分,《Form 144 | Krystal Biotech董事拟出售2.5万股股份,价值约442.08万美元》资讯为影响Krystal Biotech, Inc.的重要信息。该信息摘要如下:根据美国证券交易委员会美东时间6月11日披露的文件,$Krystal Biotech $董事SUMA KRISHNAN拟于6月11日出售2.5万股普通股股份,总市值约442.08万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LGVN","KRYS"],"gpt_icon":0},{"id":"2440917954","title":"Krystal Biotech, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440917954","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440917954?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:51","pubTimestamp":1717426277,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时51分,Krystal Biotech, Inc.股票出现波动,股价急速拉升5.26%。截至发稿,该股报168.47美元/股,成交量3.0799万股,换手率0.11%,振幅4.37%。Krystal Biotech, Inc.股票所在的生物技术行业中,整体涨幅为1.29%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、Cingulate Inc C/Wts 10/12/2026 、Biocardia Inc C/Wts 06/08/2024涨幅较大,Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Affimed N.V.较为活跃,换手率分别为2844.02%、101.21%、54.17%,振幅较大的相关个股有Affimed N.V.、Bio-Path Holdings, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ,振幅分别为73.56%、72.82%、48.75%。Krystal Biotech, Inc.公司简介:Krystal Biotech Inc在美国从事医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603225117941ebedf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603225117941ebedf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2414738998","title":"美国研究综述-Agiliti、Domino's、Krystal 生物技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2414738998","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414738998?lang=zh_cn&edition=full","pubTime":"2024-02-27 19:35","pubTimestamp":1709033708,"startTime":"0","endTime":"0","summary":" 路透社2月27日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 Agiliti、多米诺比萨和 Krystal Biotech。公司要闻 * Agiliti Inc :杰富瑞将其评级从 \"买入 \"下调至 \"持有 * Autodesk Inc :加拿大皇家银行将目标价从280美元上调至290美元 * Domino's Pizza Inc :杰富瑞将目标价从400美元上调至455美元 * Itron Inc :Canaccord Genuity将目标价从68美元上调至105美元 * Krystal Biotech Inc :Evercore ISI将该股从战术跑赢大盘名单中除名 以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1992135472.HKD","ITRI","GH","LLY","KRYS","CRWD","GTLB","CARG","DV","FATE","CDE","ANRO","LU0106831901.USD","GNSS","FIS","DVA","CABO","CPRT","LNG","COGT","LU2286300806.USD","EGLE","LU1023059063.AUD","LU0109391861.USD","APA","FRPT","U","GVA","DPZ","LU0661504455.SGD","GNK","MSTR","EFX","BK4077","LU0708995401.HKD","LU1057294990.SGD","ASLE","BECN","BASE","IE00BJT1NW94.SGD","LU0061475181.USD","AFRM","BK4524","INVH","AGTI","DKNG","ADSK","BK4187","FLT","EVER"],"gpt_icon":0},{"id":"2414849832","title":"美国研究综述-Agiliti、多米诺比萨、Krystal 生物技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2414849832","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414849832?lang=zh_cn&edition=full","pubTime":"2024-02-27 15:31","pubTimestamp":1709019083,"startTime":"0","endTime":"0","summary":" 路透社2月27日 - 华尔街证券分析师周二调整了对 Agiliti、多米诺比萨和 Krystal Biotech 等几家美国上市公司的评级和目标价。公司要闻 * Agiliti公司 :杰富瑞将其评级从 \"买入 \"下调至 \"持有 * 多米诺比萨 :杰富瑞将目标价从400美元上调至455美元 * Krystal Biotech Inc :Evercore ISI将其股票从战术跑赢大盘名单中除名 以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014880.SGD","BK4535","RARE","NDSN","QTWO","LU2491049909.HKD","LU2491050071.SGD","TMDX","VCYT","GH","BECN","INVH","CARG","AFRM","DKNG","FRPT","SG9999001176.SGD","LU2430703178.SGD","LLY","EVER","ITRI","OPAD","PUBM","AGTI","KRYS","ANRO","WDAY","VMI","MSTR","WRB","STAA","CDE","BK4534","COGT","PCG","SFM","WMT","FIS","LU2264538146.SGD","UPST","WYNN","DVA","BK4533","LU1280957306.USD","DPZ","LU2430703251.USD","TREX","LU1804176565.USD","EFX","FATE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.krystalbio.com","stockEarnings":[{"period":"1week","weight":-0.0172},{"period":"1month","weight":0.1097},{"period":"3month","weight":-0.0015},{"period":"6month","weight":0.4785},{"period":"1year","weight":0.5195},{"period":"ytd","weight":0.4316}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.041},{"period":"3month","weight":0.057},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.2371},{"period":"ytd","weight":0.1551}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Krystal Biotech, Inc.于2016年4月开始运营。2017年3月,他们从加利福尼亚州有限责任公司转换为特拉华州C-corporation,并将其名称从Krystal Biotech, LLC更改为Krystal Biotech, Inc。该公司是一家专注于为罕见病患者开发和商业化基因药物的生物技术公司。利用他们基于工程化HSV-1的专利平台,他们创造了载体,可以有效地将治疗性转基因传递给多器官系统中感兴趣的细胞。然后,细胞自身的机制转录并翻译编码的效应物来治疗或预防疾病。他们在医疗保健专业人员的办公室或可能由医疗保健专业人员在患者家中制定无创或微创给药途径的载体。他们的目标是开发易于使用的药物,以显著改善患有罕见疾病和慢性疾病的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.00628},{"month":2,"riseRate":0.714286,"avgChangeRate":0.089681},{"month":3,"riseRate":0.571429,"avgChangeRate":0.056874},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015567},{"month":5,"riseRate":0.571429,"avgChangeRate":0.051502},{"month":6,"riseRate":0.714286,"avgChangeRate":0.119067},{"month":7,"riseRate":0.571429,"avgChangeRate":0.046706},{"month":8,"riseRate":0.166667,"avgChangeRate":0.002705},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.071903},{"month":10,"riseRate":0.571429,"avgChangeRate":0.058731},{"month":11,"riseRate":0.857143,"avgChangeRate":0.208875},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.00422}],"exchange":"NASDAQ","name":"Krystal Biotech Inc.","nameEN":"Krystal Biotech Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Krystal Biotech Inc.(KRYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Krystal Biotech Inc.(KRYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Krystal Biotech Inc.,KRYS,Krystal Biotech Inc.股票,Krystal Biotech Inc.股票老虎,Krystal Biotech Inc.股票老虎国际,Krystal Biotech Inc.行情,Krystal Biotech Inc.股票行情,Krystal Biotech Inc.股价,Krystal Biotech Inc.股市,Krystal Biotech Inc.股票价格,Krystal Biotech Inc.股票交易,Krystal Biotech Inc.股票购买,Krystal Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Krystal Biotech Inc.(KRYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Krystal Biotech Inc.(KRYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}